Your browser doesn't support javascript.
loading
Precisional detection of lymph node metastasis using tFCM in colorectal cancer.
Yang, Dan; Tang, Jingling; Zhen, Yunhuan; Yuan, Jindong; Hu, Pingsheng; Li, Xiaoyun; Du, Hang; Zhang, Xiaolan; Yang, Yuan.
Afiliação
  • Yang D; Clinical Medical Research Center, The Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Road, Yunyan Zone, Guiyang 550004, Guizhou, China.
  • Tang J; Clinical Medical Research Center, The Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Road, Yunyan Zone, Guiyang 550004, Guizhou, China.
  • Zhen Y; Department of Anorectal Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Yuan J; Department of Anorectal Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Hu P; Department of Research and Development, Sinorda Biotechnology Co., Ltd, Guiyang, Guizhou, China.
  • Li X; Department of Anorectal Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Du H; Clinical Medical Research Center, The Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Road, Yunyan Zone, Guiyang 550004, Guizhou, China.
  • Zhang X; Department of Anorectal Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Yang Y; Clinical Medical Research Center, The Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Road, Yunyan Zone, Guiyang 550004, Guizhou, China.
Open Life Sci ; 18(1): 20220780, 2023.
Article em En | MEDLINE | ID: mdl-38152574
ABSTRACT
The detection of colorectal cancer (CRC) lymph node (LN) metastases significantly influences treatment choices, yet identifying them in samples is time-consuming and error-prone. To enhance efficiency, we have established a LN metastasis detection method utilizing triple-parameter flow cytometry (tFCM) and have conducted a comparative assessment of its accuracy and cost-effectiveness in contrast to conventional pathological examinations. This technique utilized biomarkers cytokeratin 20 (CK20), epithelial cell adhesion molecules (EpCAM), and Pan-CK. tFCM's sensitivity was validated by analyzing known cell line concentrations (SW480 and SW620) in peripheral blood mononuclear cells (PBMCs), with CK20, EpCAM, and Pan-CK showing significant expression in CRC cell lines but not in PBMCs. A strong linear correlation was observed in the mixed leukocyte environment (R 2 = 0.9988). Subsequently, tFCM and pathological sections were employed to analyze LNs from CRC patients, enabling comparison of detection accuracy. Within the 36 LNs studied, tFCM successfully identified tumor cells with varying metastasis degrees, including micro-metastasis and isolated tumor cell clusters. Notably, relying solely on pathological sections led to a potential 25% misdiagnosis rate for LNs. In contrast, tFCM effectively minimized this risk. In summary, compared to traditional pathological sections, tFCM is a more advantageous method for detecting nodal metastasis in CRC patients, offering a more precise prognosis for these patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Life Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Polônia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Life Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Polônia